Jun. 1 at 11:45 PM
$ADMA The most recent time that Adam Grossman publicly stated that ADMA could reach roughly
$1 billion in annual revenue appears to be January 13, 2025.
In a company business update, Grossman said that newly executed long-term plasma supply agreements “should position us to potentially achieve
$1 billion in total annual revenue before 2030.”
He reiterated and expanded that target several times afterward:
March 2025 (Q4 2024 earnings call): Grossman said that ASCENIV alone could surpass
$1 billion in annual revenue and referred to the company’s “
$1 billion total annual revenue guidance expected to be realized prior to 2030.”
